A lawsuit filed Monday accused three makers of insulin — Sanofi, Novo Nordisk and Eli Lilly — of conspiring to drive up the prices of their lifesaving drugs, harming patients who were being asked to pay for a growing share of their drug bills.
A lawsuit filed Monday accused three makers of insulin — Sanofi, Novo Nordisk and Eli Lilly — of conspiring to drive up the prices of their lifesaving drugs, harming patients who were being asked to pay for a growing share of their drug bills. File photo by James Estrin The New York Times
A lawsuit filed Monday accused three makers of insulin — Sanofi, Novo Nordisk and Eli Lilly — of conspiring to drive up the prices of their lifesaving drugs, harming patients who were being asked to pay for a growing share of their drug bills. File photo by James Estrin The New York Times

Lawsuit accuses three drugmakers of fixing insulin prices

January 30, 2017 11:21 PM

More Videos

  • Flu spike hits hospitals amid IV bag shortage

    Hospitals in Kansas City and across the country are having to get creative as they fight an early flu season and a months-long shortage of IV bags tied to Hurricane Maria.